Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GTF3C2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | HCFC1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | WDR18 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | RAD54L | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | NUDT21 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | LIMA1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | RBBP4 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | TADA1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | CBX8 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ZDHHC24 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |